Published TCIMAIL newest issue No.198
Maximum quantity allowed is 999
Please select the quantity
Receptor Tyrosine Kinase (RTK) Inhibitors
RTKs (Receptor tyrosine kinases) are transmembrane glycoproteins present on cell surface that activate various kinds of main cell signaling pathways like MAPK pathway and PI3K pathway. They're important molecules in biological phenomenon to control basic cell activities such as proliferation, differentiation, survival and death. Their excess expression and active mutation have been reported in cancer cells. Numerous specific low molecular-weight drugs and antibodies designed to inhibit their activities have been developed.
Explore Receptor Tyrosine Kinase (RTK) Inhibitors Categories
- Home
- Products
- Life Science
- Cell Biology
- Cancer Research
- Antitumor Agents for Research
- Tyrosine Kinase Inhibitors [Antitumor Agents]
- Receptor Tyrosine Kinase (RTK) Inhibitors
- Home
- Products
- Life Science
- Cell Biology
- Cell Signaling and Neuroscience
- Kinase/Phosphatase Biology
- Receptor Tyrosine Kinase (RTK) Inhibitors
- Home
- Products
- Life Science
- Cell Biology
- Cell Signaling and Neuroscience
- Kinase/Phosphatase Biology
- {Disable Category} Receptor Tyrosine Kinase Biology [Cell signaling]
- Receptor Tyrosine Kinase (RTK) Inhibitors